Filter
1997
Filtered Results: 1997
Text search:
European
Centre
for
disease
prevention
and
Control
Featured
Recommendations
189
New Publications
396
Language
Document type
No document type
978
Studies & Reports
416
Guidelines
315
Manuals
112
Strategic & Response Plan
60
Fact sheets
47
Situation Updates
23
Training Material
19
Resource Platforms
9
Infographics
7
Online Courses
5
Brochures
3
Videos
3
Countries / Regions
Western and Central Europe
160
Global
85
Ukraine
51
Eastern Europe
49
Sierra Leone
38
India
36
Africa
30
Germany
27
Eastern Europe and Central Asia
27
Russia
27
Liberia
25
Zambia
19
Kenya
19
Nepal
17
Guinea
16
Uganda
16
South Africa
16
Myanmar / Burma
16
Ethiopia
15
West and Central Africa
15
Latin America and the Carribbean
15
Nigeria
13
Ghana
13
Asia
13
Syria
12
Middle East and North Africa
12
Brazil
11
Malawi
10
Moldova
10
Senegal
9
Rwanda
9
South–East Asia Region
9
Albania
9
Burkina Faso
8
Tanzania
8
Cambodia
8
Bangladesh
8
Namibia
8
East and Southern Africa
8
Tajikistan
8
Philippines
7
Mozambique
7
Congo, Democratic Republic of
6
Pakistan
6
South Sudan
6
Thailand
6
North Macedonia
6
Madagascar
6
Afghanistan
5
Western Pacific Region
5
Poland
5
Romania
5
Georgia
5
Zimbabwe
4
Benin
4
Hungary
4
Lesotho
4
Cameroon
3
Haiti
3
Somalia
3
Jordan
3
China
3
Eswatini/ Swaziland
3
Colombia
3
Ecuador
3
Botswana
3
Paraguay
3
Armenia
3
Laos
3
Vietnam
3
Turkmenistan
3
Spain
3
Belarus
3
Guinea-Bissau
2
Côte d’Ivoire / Ivory Coast
2
USA
2
Niger
2
Turkey
2
Indonesia
2
Sudan
2
Central African Republic
2
Greece
2
Angola
2
Sri Lanka
2
Yemen
2
Venezuela
2
Italy
2
Congo-Brazzaville
2
Bulgaria
2
Estonia
2
Slovakia
2
Uzbekistan
2
Kyrgyzstan
2
Kazakhstan
2
Belgium
2
France
2
Bosnia and Herzegovina
2
Mali
1
Morocco
1
Saudi Arabia
1
Iraq
1
Lebanon
1
Mauritania
1
Ireland
1
Argentina
1
Dominican Republic
1
Peru
1
Serbia
1
Burundi
1
El Salvador
1
Other region
1
Bhutan
1
Canada
1
Qatar
1
Lithuania
1
Iran
1
North America
1
Gabon
1
Denmark
1
Mauritius
1
Tunisia
1
United Kingdom
1
Portugal
1
Azerbaijan
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
447
Clinical Guidelines
176
Public Health
129
Key Resources
85
Women & Child Health
55
Capacity Building
21
Pharmacy & Technologies
19
Toolboxes
COVID-19
254
Mental Health
198
HIV
186
TB
174
AMR
134
Rapid Response
119
Ebola
86
Planetary Health
83
Refugee
52
Conflict
49
NCDs
46
Zika
45
Global Health Education
43
Caregiver
40
Pharmacy
30
Disability
28
NTDs
23
Health Financing Toolbox
21
Specific Hazards
13
Polio
12
Natural Hazards
9
Cholera
7
Social Ethics
3
Global Fund Investment Guidance for Eastern Europe and Central Asia
Accessed: 29.09.2019
Antimicrobial resistance (AMR) surveillance plays an important role in the early detection of resistant strains of public health importance and prompt response to outbreaks in hospitals and the comm...
Multiple countries are reporting severe acute cases of hepatitis of unknown aetiology in children, in several
regions of the world. WHO has developed this clinical case report form (CRF) to support and facilitate reporting
of anonymized, patient-l...
A manual for programme managers.
There is a substantial and ever-increasing unmet need for rehabilitation worldwide, which is particularly profound in low- and middle
-income coun...
The global burden of disease associated with air pollution exposure exacts a massive toll on human health worldwide: exposure to air pollution is estimated to cause millions of deaths and lost years...
Plos Neglected Tropical Diseases 8(11): e3229 (20 November 2014)
The Strategic Framework for Emergency Preparedness is a unifying framework which identifies the principles and elements of effective country health emergency preparedness. It adopts the major lesson...
In 2005, the World Health Organization (WHO) Member States adopted the revised International
Health Regulations (IHR) (2005). The Regulations provide a unique public health framework in the
form of obligations and reco...
Antimicrobial resistance (AMR) is an important public health concern shared by developed and developing countries. In developing countries the burden of infectious diseases is greater ... exacerbated by limited access to, and availability and affordability of, antimicrobials required to treat infections caused by AMR organisms. With drugs not listed on the essential drugs list (EDL), problems of increased morbidity, costs of extended hospitalisation and mortality are extremely serious. The problem of susceptibility to and spread of infections caused by multidrug-resistant (MDR) infectious agents is fuelled by factors such as limited access to clean water and sanitation to ensure personal hygiene, malnutrition, and the HIV/TB epidemic.
Following review of evidence and advice from the Technical Advisory Group (TAG) on Tuberculosis (TB) Diagnostics and Laboratory Strengthening, the World Health Organization (WHO) announces that cur...
On 15–16 December 2020, WHO and the Medicines for Malaria Venture co-convened a technical consultation to consider the preferred product characteristics (PPCs) ... drugs used in malaria chemoprevention. The main goal of the technical consultation was to agree on the most important PPCs for drugs to protect populations from malaria (chemoprevention), while considering relevant measures of efficacy and the safety data needed to support WHO policy recommendations.
Background: The impacts of air pollutants on health range from short-term health impairments to hospital admissions
and deaths. Climate change is leading to an increase in air pollution.
These guidelines have been developed to provide guidance to the Ministry of Health in managing applications for registration of human pharmaceutical products in Rwanda. It was compiled by the Technical Working Group (TWG) on Medicines Evaluation ... Registration (MER) of the East African Community Medicine Regulatory Harmonization (EAC MRH) Project. The group relied on their experiences and knowledge on medicines registration requirements of their individual Countries. World Health Organization (WHO) and the International Conference on Harmonization of Technical Requirements of Medicines for Human Use (ICH) and other available literature.
Made under Section 5 (c) of the Tanzania Food, Drugs and Cosmetics Act, 2003 | Second Edition
Nature Reviews Microbiology Vol. 17 (2019)pp.51-62
Antimicrobial susceptibility testing (AST) technologies help to accelerate the
initiation of targeted antimicrobial therapy for patients with infections ... could potentially
extend the lifespan of current narrow- spectrum antimicrobials. Although conceptually new and
rapid AST technologies have been described, including new phenotyping methods, digital
imaging and genomic approaches, there is no single major, or broadly accepted, technological
breakthrough that leads the field of rapid AST platform development
The objectives of pertussis surveillance are to:hmonitor disease burden and the impact of the pertussis vaccination programme, with a special focus on understanding the morbidity ... mortality in children < 5 years of agehgenerate data to inform vaccine schedule and delivery strategy decisions to optimize the impact of vaccinationhdetect and guide public health response to outbreaks of pertussis
his guidance provides interim guidance for the integration of SARS-CoV-2 and influenza virologic and genomic surveillance, from sentinel site case ...
an operational guide to support all those responsible for planning and implementing the rollout of COVID-19 vaccine to refugees and migrants at nat...
International Perspectives and Future Directions
